ITGAM and melanoma: Furthermore, treatment with TA99 alone and in combination with anti-CTLA4, but not anti-CTLA4 alone, induced an increase in the percent of dendritic cells (CD11b+CD11c+) infiltrating B16 subcutaneous melanomas (Figure 3C).